Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126827181 | 12682718 | 1 | I | 201212 | 20160720 | 20160825 | 20160825 | EXP | CA-ORION CORPORATION ORION PHARMA-TREX2016-1135 | ORION | 56.00 | YR | F | Y | 0.00000 | 20160825 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126827181 | 12682718 | 1 | PS | METHOTREXATE (TRADE NAME UNKNOWN) | METHOTREXATE | 1 | Unknown | 0 | 25 | MG | /wk | ||||||||
| 126827181 | 12682718 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 1032906 | 0 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||
| 126827181 | 12682718 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 0 | 5 | MG | TABLET | BID | |||||||
| 126827181 | 12682718 | 4 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 0 | |||||||||||
| 126827181 | 12682718 | 5 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | 0 | 40 | MG | QOW | ||||||||
| 126827181 | 12682718 | 6 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | 0 | 1 | G | |||||||||
| 126827181 | 12682718 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 0 | |||||||||||
| 126827181 | 12682718 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 126827181 | 12682718 | 9 | SS | ARAVA | LEFLUNOMIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 126827181 | 12682718 | 10 | C | GOLD | GOLD | 1 | Unknown | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126827181 | 12682718 | 1 | Rheumatoid arthritis |
| 126827181 | 12682718 | 2 | Rheumatoid arthritis |
| 126827181 | 12682718 | 3 | Rheumatoid arthritis |
| 126827181 | 12682718 | 4 | Rheumatoid arthritis |
| 126827181 | 12682718 | 5 | Rheumatoid arthritis |
| 126827181 | 12682718 | 6 | Rheumatoid arthritis |
| 126827181 | 12682718 | 7 | Rheumatoid arthritis |
| 126827181 | 12682718 | 8 | Rheumatoid arthritis |
| 126827181 | 12682718 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126827181 | 12682718 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126827181 | 12682718 | Abdominal discomfort | |
| 126827181 | 12682718 | Back pain | |
| 126827181 | 12682718 | Blood pressure increased | |
| 126827181 | 12682718 | Drug ineffective | |
| 126827181 | 12682718 | Dysphagia | |
| 126827181 | 12682718 | Femur fracture | |
| 126827181 | 12682718 | Gait disturbance | |
| 126827181 | 12682718 | Haemorrhage | |
| 126827181 | 12682718 | Hypersensitivity | |
| 126827181 | 12682718 | Intervertebral disc degeneration | |
| 126827181 | 12682718 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126827181 | 12682718 | 2 | 20121108 | 0 | ||
| 126827181 | 12682718 | 3 | 20150905 | 0 | ||
| 126827181 | 12682718 | 5 | 20130506 | 20131008 | 0 | |
| 126827181 | 12682718 | 6 | 20131022 | 20140507 | 0 | |
| 126827181 | 12682718 | 8 | 2004 | 0 |